PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat with the devastating COVID-19. The pharmacological activities of N-acetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID19 make it a promising therapeutic agent in COVID-19. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions.
is ?:annotates of
?:creator
?:journal
  • Mini-reviews_in_medicinal_chemistry_(Online)
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19
?:type
?:who_covidence_id
  • #895211
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/qfrvqxo4>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/qfrvqxo4>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all